Concord Biotech Limited (CONCORDBIO.BO)
INR 1658.55
(0.36%)
INR 1658.55
(0.36%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 97.37 Million INR | -69.13% |
| 2022 | 315.47 Million INR | -49.52% |
| 2021 | 624.93 Million INR | -30.01% |
| 2020 | 892.83 Million INR | 71.52% |
| 2019 | 520.54 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 97.37 Million INR | 0.0% |
| 2023 Q2 | 229.66 Million INR | 0.0% |
| 2023 FY | 97.37 Million INR | -69.13% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | 0.0% |
| 2022 FY | 315.47 Million INR | -49.52% |
| 2022 Q4 | 315.47 Million INR | 0.0% |
| 2021 FY | 624.93 Million INR | -30.01% |
| 2020 FY | 892.83 Million INR | 71.52% |
| 2019 FY | 520.54 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 92.821% |
| Biocon Limited | 162.76 Billion INR | 99.94% |
| Blue Jet Healthcare Limited | 16.12 Million INR | -503.695% |
| Dishman Carbogen Amcis Limited | 23.12 Billion INR | 99.579% |
| FERMENTA BIOTECH LIMITED | 1.32 Billion INR | 92.638% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 586.5 Million INR | 83.397% |
| Panacea Biotec Limited | 209.9 Million INR | 53.608% |
| SAMSRITA LABS LIMITED | 22.03 Million INR | -341.975% |
| Servoteach Industries Limited | 5059.00 INR | -1924707.274% |
| SMS Lifesciences India Limited | 1 Billion INR | 90.332% |
| Supriya Lifescience Limited | 54.88 Million INR | -77.434% |
| Syngene International Limited | 5.55 Billion INR | 98.246% |
| TAKE Solutions Limited | 370.85 Million INR | 73.742% |
| Titan Biotech Limited | 83.02 Million INR | -17.28% |
| Transgene Biotek Limited | 140.01 Million INR | 30.451% |
| Vanta Bioscience Limited | 609.53 Million INR | 84.025% |